Action brought on 23 June 2021 – Hecht Pharma v EUIPO – Gufic Biosciences (Gufic)

(Case T-346/21)

Language in which the application was lodged: German

Parties

Applicant: Hecht Pharma GmbH (Bremervörde, Germany) (represented by: C. Sachs and J. Sachs, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Gufic Biosciences Ltd. (Mumbai, India)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: EU word mark Gufic – EU trade mark No 8 613 044

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 3 June 2021 in Case R 2738/2019-2

Form of order sought

The applicant claims that the Court should:

annul the contested decision and also declare EU trade mark No 8 613 044 ‘Gufic’ revoked in respect of Class 5 ‘Medicines’;

order Gufic Biosciences Ltd. to pay the costs of the appeal proceedings and of the pre-litigation procedure.

Plea in law

Infringement of Article 58(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

____________